{"id":5629,"date":"2008-03-14T14:51:00","date_gmt":"2008-03-14T14:51:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5629"},"modified":"2022-04-13T13:07:45","modified_gmt":"2022-04-13T13:07:45","slug":"regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/","title":{"rendered":"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis"},"content":{"rendered":"
\n

Emilio Cuadrado<\/a> 1<\/a><\/sup>, Marta Alonso<\/a>, Maria-Dolores de Juan<\/a>, Pilar Echaniz<\/a>, Juan-Ignacio Arenas<\/a>, World J Gastroenterol. 2008 Mar 14;14(10):1521-7.<\/p>\n<\/div>\n\n

\n

The clinical efficacy of GMA on IBD and related extra intestinal manifestations was associated with an expansion of circulating CD4+ CD25+ Tregs and higher expression of FoxP3 in CD4+ T cells. Accordingly, an elevated CD4+ CD25+ FoxP3 may be a valuable index of remission in patients with IBD and other chronic relapsing-remitting inflammatory conditions during treatment with GMA.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/18330941\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2693745\/pdf\/WJG-14-1521.pdf<\/a><\/p>\n<\/div>\n\n

\n

<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Emilio Cuadrado 1, Marta Alonso, Maria-Dolores de Juan, Pilar Echaniz, Juan-Ignacio Arenas, World J Gastroenterol. 2008 Mar 14;14(10):1521-7. The clinical efficacy of GMA on IBD and related extra intestinal manifestations was associated with an expansion of circulating CD4+ CD25+ Tregs and higher expression of FoxP3 in CD4+ T cells. Accordingly, an elevated CD4+ CD25+ FoxP3 may be a valuable index […]<\/p>\n","protected":false},"template":"","scientific_tags":[159,314,179,312,173,90,306],"class_list":["post-5629","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-crohns-disease","scientific_tags-digestive","scientific_tags-foxp3-t-cells","scientific_tags-immunology","scientific_tags-moa","scientific_tags-tregs","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"\nRegulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Emilio Cuadrado 1, Marta Alonso, Maria-Dolores de Juan, Pilar Echaniz, Juan-Ignacio Arenas, World J Gastroenterol. 2008 Mar 14;14(10):1521-7. The clinical efficacy of GMA on IBD and related extra intestinal manifestations was associated with an expansion of circulating CD4+ CD25+ Tregs and higher expression of FoxP3 in CD4+ T cells. Accordingly, an elevated CD4+ CD25+ FoxP3 may be a valuable index […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-13T13:07:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/\",\"name\":\"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2008-03-14T14:51:00+00:00\",\"dateModified\":\"2022-04-13T13:07:45+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/","og_locale":"fr_FR","og_type":"article","og_title":"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte","og_description":"Emilio Cuadrado 1, Marta Alonso, Maria-Dolores de Juan, Pilar Echaniz, Juan-Ignacio Arenas, World J Gastroenterol. 2008 Mar 14;14(10):1521-7. The clinical efficacy of GMA on IBD and related extra intestinal manifestations was associated with an expansion of circulating CD4+ CD25+ Tregs and higher expression of FoxP3 in CD4+ T cells. Accordingly, an elevated CD4+ CD25+ FoxP3 may be a valuable index […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/","og_site_name":"Adacyte","article_modified_time":"2022-04-13T13:07:45+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/","name":"Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2008-03-14T14:51:00+00:00","dateModified":"2022-04-13T13:07:45+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/regulatory-t-cells-in-patients-with-inflammatory-bowel-diseases-treated-with-adacolumn-granulocytapheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5629"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}